Chemical Structure : HDACi-4b
CAS No.: 537034-15-4
货号: PC-42126Not For Human Use, Lab Use Only.
A benzamide-type HDAC inhibitor with IC50 of 78 uM for changes of FXN mRNA in affected GM15850 cells.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥1280 | In stock | |
50 mg | ¥1980 | In stock | |
100 mg | ¥3280 | In stock | |
200 mg | Get quote | ||
1 g | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
HDACi-4b (NKL22) is a benzamide-type HDAC inhibitor with IC50 of 78 uM for changes of FXN mRNA in affected GM15850 cells.
HDACi-4b (NKL22) reverses FXN silencing in primary lymphocytes from individuals with Friedreich's ataxia.
HDACi-4b (NKL22) directly affects the histones associated with FXN, increasing acetylation at particular lysine residues on histones H3 and H4 (H3K14, H4K5 and H4K12).
HDACi-4b (NKL22) significantly improves motor performance, overall appearance, and body weight in an HD mouse model.
分子量 | 325.4048 | |
分子式 | C19H23N3O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 29 mg/mL |
|
Chemical Name/SMILES |
Heptanediamide, N1-(2-aminophenyl)-N7-phenyl- |
1. Jia H, et al. Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):E56-64.
2. Thomas EA, et al. Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15564-9.
3. Herman D, et al. Nat Chem Biol. 2006 Oct;2(10):551-8.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright